Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

39 trials with published results (18%)

Research Maturity

124 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

8.3%

18 terminated out of 218 trials

Success Rate

87.3%

+0.8% vs benchmark

Late-Stage Pipeline

7%

16 trials in Phase 3/4

Results Transparency

31%

39 of 124 completed with results

Key Signals

39 with results87% success18 terminated

Data Visualizations

Phase Distribution

171Total
Not Applicable (116)
Early P 1 (4)
P 1 (24)
P 2 (11)
P 3 (10)
P 4 (6)

Trial Status

Completed124
Unknown29
Recruiting20
Terminated18
Active Not Recruiting8
Not Yet Recruiting8

Trial Success Rate

87.3%

Benchmark: 86.5%

Based on 124 completed trials

Clinical Trials (218)

Showing 20 of 20 trials
NCT05776277Phase 3Active Not RecruitingPrimary

Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury

NCT07711509Not ApplicableActive Not Recruiting

Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Rectal Cancer

NCT04976153Phase 3RecruitingPrimary

Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence

NCT06221046Not ApplicableNot Yet Recruiting

Testing the Safety and Efficacy of a Novel Barrier Cream for the Treatment of Moisture Associated Skin Damage

NCT07499258Not Yet RecruitingPrimary

Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence

NCT04806386Not ApplicableCompletedPrimary

The Role of Fiber in the Prevention and Treatment of Fecal Incontinence

NCT07524439Not ApplicableRecruitingPrimary

Improving the Care of Incontinence-Associated Dermatitis (IAD) Using a Beta-Glucan Cream as a Hydrating and Soothing Agent

NCT06370637Not ApplicableNot Yet Recruiting

Testing a Novel Barrier Cream for Fecal Incontinence in an Ambulatory Population

NCT06785844Early Phase 1RecruitingPrimary

Intra-rectal Botulinum Toxin Injection for Intractable Non-retentive Fecal Incontinence in Children - an Open Label Pilot Study

NCT04506593Recruiting

Indiana University Gastrointestinal Motility Diagnosis Registry

NCT06273046Not ApplicableRecruitingPrimary

Treatment of Fecal Incontinence and Functional Evacuation Disorders Using Non-instrumental Biofeedback

NCT00213317Completed

Effect of Lumbo-sacral Magnetic Stimulation on Colonic Motility

NCT01786304Not ApplicableCompletedPrimary

Effect of Sacral Nerve Stimulation on Enteric Nervous System

NCT07604415Not ApplicableRecruitingPrimary

Active Versus Passive Anal Sphincter Training in Patients With Fecal Incontinence

NCT07603232Enrolling By Invitation

Long-Term Health Outcomes in Children Born With Hirschsprung's Disease and Anorectal Malformations at the Colorectal Centre of Excellence in Quebec

NCT05773742Not ApplicableCompleted

Treatment of Fecal Incontinence and Chronic Constipation With Low-volume Irrigation

NCT01786317Not ApplicableCompletedPrimary

Anal Motor Function in Fecal Incontinence

NCT05708612Not ApplicableActive Not RecruitingPrimary

Safety and Performance of a Silicone Implant for Fecal Incontinence Treatment (SimplyFI)

NCT05200923Not ApplicableRecruiting

Pelvic Health Electrically Evoked Recording (PEER) 2 Study

NCT05396456Not ApplicableRecruitingPrimary

Autologous Muscle Fiber Fragment Injections

Scroll to load more

Research Network

Activity Timeline